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asthma; basement membrane perimeter; remodeling THE PERIMETER OF THE AIRWAY basement membrane (Pbm), measured in airways cut in cross sections has been used as a marker of airway size for a number of years in a variety of airway diseases (3, 5, 21) and in experimental animal models (2, 4, 6, 17) , since it appears to be independent of the degree of smooth muscle shortening and/or lung inflation (11, 14) . It has been useful to compare the morphometric dimensions and inflammation of airways from different parts of the lung (1) and from different subjects, where it is usually impossible to systematically sample airways to ensure that comparisons are from the same site in the lung, as is possible when using CT scans (16) . What is not clear is the extent to which the airway pathology associated with asthma alters the airway Pbm itself. If remodeling due to asthma results in a reduction of the length of the Pbm in patients with asthma, then using it to compare airways will result in comparison of bigger airways from asthma cases, with smaller airways in nonasthma cases. Given that the thickness of the airway wall, including the smooth muscle, increases with airway size, this would result in a spurious increase in airway wall thickness in asthma when comparing airways.
Our laboratory has previously shown a small effect of postmortem lung inflation, on the length of the Pbm. However, this increase in length did not account for the differences observed in the amount of airway smooth muscle between cases of asthmatic subjects and nonasthmatic controls (10) . The aim of the present study was to assess the effect of asthma of varying severity on the length of the basement membrane in airways where an identical systematic sampling protocol has been used in cases of asthmatic and control subjects.
METHODS
Subjects. Subjects used in this study were postmortem cases collected for the Prairie Provinces Asthma Study, a multicenter study of asthma fatalities occurring in Alberta, Saskatchewan, and Manitoba from November 1992 to October 1995 (7, 22) . This study received ethical approval from the University of Calgary Conjoint Ethics Committee and from the Sir Charles Gairdner Hospital Human Ethics Committee. Informed consent was obtained from the next-of-kin for pathological studies of lung tissues. Cases were defined as subjects who had died of asthma (fatal asthma); had died of nonrespiratory causes but subsequently shown to have a history of asthma (nonfatal asthma); and subjects who had died of nonrespiratory causes and had no history of respiratory disease (control subjects). After death, the study team contacted the next of kin to obtain consent for autopsy. The next of kin were asked to complete a questionnaire that sought information on asthma severity, age of onset, duration of asthma, asthma medications, and smoking history and assigned a category for asthma severity based on 2005 guidelines from the Global Initiative for Asthma (http://www.ginasthma.org/documents/2/documents_vari-ants/12). In addition, medication history was supplemented with pharmacy records obtained (with permission) from the next of kin of the asthma subjects (fatal asthma and nonfatal asthma) and their health care provider.
Tissue sampling. Left lungs were taken at autopsy and fixed in inflation via the blood vessels and airways with isotonic glutaraldehyde fixative (2.5% in 0.1 M phosphate buffer, pH 7.3) at a differential pressure of 20 cmH 2O. The dual fixation method was developed to circumvent the poor airway perfusion resulting from mucous plugs in the cases of fatal asthma. A stratified sampling technique was applied. In brief, a 1-mm-diameter silver probe was used to identify the axial airway path for each lobar segment. The probe was inserted into the pulmonary artery accompanying the main bronchus of the left upper lobe and the anterior and posterior bronchus of the left lower lobe and passed down to the lung periphery. The pleural surface beyond the tip of the probe was marked with a dye. The lobe-specific measured length of the path from its origin in the lobar bronchus to the distal lung pleura was then divided into nine equidistant levels and transverse blocks were cut at each level to obtain samples from the main bronchus (level 9) to the terminal bronchioles (level 1). This sampling procedure was developed to ensure that similar anatomic levels (generations) of airways were sampled, regardless of lung size. Tissue blocks were embedded in paraffin wax, sectioned at 5 m, mounted on glass slides, and stained with hematoxylin and eosin, and a Masson Trichrome and Verhoeff stain.
Morphometry. The Pbm was determined by counting intersections of the Pbm with a square-lattice grid of known dimensions using a Zeiss-Axioplan light microscope and drawing tube. At a known magnification, the grid was placed at random over a cross section of airway; the number of intersections between the grid lines and the luminal aspect of the epithelial basement membrane (laminar reticularis) were counted; and the perimeter was calculated: Pbm ϭ /2·d·I, where I is the number of intersections, and d is the distance between grid lines (8) . All measurements were made by two observers, with a coefficient of correlation for Pbm between observers of 98%.
Statistical analysis. Summary statistics, including means and SDs for normally distributed variables, medians, and interquartile ranges for nonnormally distributed variables and counts, and percentages for categorical variables, were calculated. Subject characteristics were compared with independent sample t-tests for continuous variables and 2 tests for categorical variables. Linear mixed models were conducted to assess the relationships between the dependent variable Pbm and the independent variables, age, sex, smoking status, height, level, and asthma group, with two-way interactions investigated. Pbm was log-transformed for analysis purposes, and results are, therefore, reported as ratios. The linear mixed model included random effects to account for correlated responses. Subject and lobe were included as random effects. Statistical significance was set at 0.05. All data were analyzed using programming language R, version 3.0.1 (19) .
RESULTS
There were no significant differences seen in age, height, sex, or smoking status between the study groups (Table 1) . Of the 55 cases of asthma, 29% had asthma as the primary cause of death (fatal asthma), but there were no significant differences in the age of onset of asthma, or duration of asthma. The percentage of asthmatic subjects with severe asthma (based on severity score from available clinical histories) was significantly greater (P ϭ 0.004) in the fatal asthma group compared with the nonfatal asthma group. The cases of fatal asthma reported a lower use of inhaled (0.057), and significantly increased use of oral, corticosteroids (P Ͻ 0.001), compared with nonfatal asthma cases. Table 2 shows the median Pbm and interquartile range for each airway level in the different case groups. Compared with control cases, the values for Pbm were reduced in the cases of asthma for smaller airways, level 5 (equivalent to an airway diameter of ϳ3 mm) down to level 1. There were no significant differences between the two asthma groups.
Univariate analysis showed significant effects on Pbm for sex (P ϭ 0.0036), height (P ϭ 0.0058), airway level (P Ͻ 0.0001), and asthma group (P ϭ 0.0152), but not for smoking status (P ϭ 0.1228) and age (P ϭ 0.2863). The final model showed a significant interaction between airway level and asthma group (P Ͻ 0.001) and between airway level and sex (P Ͻ 0.001) for Pbm after adjusting for age and height. Table  3 shows the ratios for Pbm between control and combined asthma groups for each airway level, after adjustment for other variables. Significant differences in Pbm between these groups were observed at level 5 (equivalent to a diameter of ϳ3 mm) and below, whereas there are no differences in the higher levels (large airways). There were no significant differences between the two asthma groups. The results for all subject groups are shown in Fig. 1 . Table 3 also shows the ratios for Pbm between men and women. The effect of sex was significant in the larger airways, level 6 (equivalent to an airway diameter of ϳ4 mm) and above.
DISCUSSION
The present study showed that the length (perimeter) of the basement membrane, seen on airways cut in cross sections, is not significantly different in large airways between subjects with and without asthma. Therefore the length of the Pbm can be used as a reliable marker of airway size to compare the dimensions of large airways from cases of asthma with those from nonasthmatic subjects. A small (up to 20%) but systematic reduction in Pbm was observed in the medium and small airways in cases of fatal and nonfatal asthma, compared with nonasthmatic subjects. This reduction would not account for the observed differences in airway dimensions between asthmatic and nonasthmatic subjects (3, 20, 9) , except for the small airways (Pbm Ͻ 4 mm) in nonfatal cases of asthma (see below). By using a systemic sampling method, an equal number of levels (generations) from the same lobe and segment were obtained from each subject. This sampling procedure was chosen so that similar airway generations were sampled at each level, irrespective of lung size. Level, lobe, height, age, sex, and subject were used in the mixed-model analysis to correct for likely confounders and assess the effect of asthma on Pbm. The effect of asthma group was significant in the small and medium airways and was similar for nonfatal and fatal cases of asthma. The effects of sex were observed in the large airways. This may be an effect on lung volume, independent of height. We have previously observed increased size of airway smooth muscle cells in men compared with women (9).
The maximum difference in Pbm between the asthma and nonasthma groups in the present study was 20% at the peripheral levels (Fig. 1) and was similar in nonfatal and fatal cases of asthma. The observed average differences in the area of airway smooth muscle between cases of asthma for small, (Pbm Ͻ 4 mm), medium (Pbm 4-10 mm), and large (Pbm Ͼ 10 mm) are 29, 26, and 42%, respectively, for nonfatal cases of asthma and 59, 232, and 107%, respectively, for fatal cases of asthma (18) . In the present study, we found significant differences in Pbm between cases of asthma and nonasthmatic subjects of ϳ20% at level 1, decreasing to ϳ10% up to level 4. This includes airways with perimeters up to 10 mm (Table  3) . Therefore, the largest effect of the reduced Pbm relative to the measured difference observed between cases would be in the small airways of nonfatal cases (less severe clinically). We observed no effect of asthma on the estimated Pbm in the large airways (Pbm Ͼ 10 mm), the site of the greatest observed difference in airway dimensions between cases of nonfatal asthma and control subjects. In fatal cases of asthma (more severe clinically), the measured differences between groups greatly exceeds the effects of the asthma itself on the measured Level 1 represents distal airways, and level 9 represents proximal airways (relative airway levels). Pbm, basement membrane perimeter. Pbm. Therefore, we conclude that using Pbm as a marker of airway size to compare cases of asthma and control subjects is valid and likely to only introduce a significant bias in the small airways of mild and moderate (nonfatal) cases of asthma.
It was interesting to note that there were no significant differences between nonfatal and fatal cases of asthma at any airway level group, despite there being significant differences between fatal and nonfatal cases of asthma in other aspects of remodeling, such as the area of the airway smooth muscle layer (9) and the thickness of the subbasement membrane layer (12) . This suggests that small airways may be systematically reduced in caliber in asthma, regardless of severity. It has been observed that, even in community samples of asthma made predominantly of mild cases, lung function is reduced compared with those not reporting asthma (13) , and that these changes track back to early life in childhood asthma (18, 15) . In this regard, it is interesting to note that an environmental effect, cigarette smoking, had no significant effect on Pbm in any of the subject groups. Therefore, Pbm would appear as a valid marker of airway size when comparing airways from smokers and nonsmokers.
In summary, we conclude that, in the large airways, the site of greatest airway wall remodeling in asthma, the length of the Pbm is similar in asthmatic and nonasthmatic subjects. Asthma is associated with a decrease in the length of the Pbm in the medium (ϳ10%) and small airways (maximum 20%). This effect would not account for the magnitude of the observed differences in airway pathology between cases of asthma and nonasthmatic subjects, except possibly the small airways in nonfatal (mild-moderate cases) asthma. 
